Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas

Human Genetics

Volumn 97, Issue 1, 1996, Pages 91-94

  Ferrando, Adolfo A ^a   Balbín, Milagros ^a   Pendás, Alberto M ^a   Vizoso, Francisco ^a   Velasco, Gloria ^a   López Otin, Carlos ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; DNA; ENZYME INHIBITOR;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION SITE;

AMINO ACID SEQUENCE; BASE SEQUENCE; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DNA; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, NEOPLASM; EXONS; FEMALE; HUMANS; INTRONS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; TUMOR SUPPRESSOR PROTEINS;

EID: 0030058757     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00218840     Document Type: Article

References (25)

1. Balbín M. Freije JP. Abrahamson M, Velasco G, Grubb A, López-Otín C (1993) A sequence variation in the human cystatin D gene resulting in an amino acid (Cys/Arg) polymorphism at the protein level. Hum Genet 90 : 668-669
2. Caldas C, Hahn SA, Costa LT da, Redston MS, Schutte M, Seymour AB. et al (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet 8 : 27-32
3. Chedid M, Michieli P, Lengel C, Huppi K, Givol D (1994) A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIPI. Oncogene 9 : 3021-3024
4. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993) WAF1. a potential mediator of p53 tumor suppression. Cell 75 : 817-825
5. Firpo EJ, Koff A, Solomon MJ, Roberts JM (1994) Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol 14 : 4889-4901
6. Gu Y, Turck CW, Morgan DO (1993) Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710
7. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8 : 2939-2952
8. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371 : 257-261
9. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p2I Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75 : 805-816
10. Hunter T, Pines J (1994) Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79 : 573-582
11. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis A, Ding W, et al. (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 8 : 22-26
12. Li YJ, Laurent-Puig P, Salmon RJ, Thomas G, Hamelin R (1995) Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene 10 : 599-601
13. Marchetti A. Buttitta F, Pellegrini S, Bertacca G, Lori A, Bevilacqua G (1995) Absence of somatic mutations in the coding region of the WAF1/CIP1 gene in human breast, lung and ovarian carcinoma: a polymorphism at codon 31. Int J Oncol 6: 187-189
14. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y (1994) Frequent somatic mutation of the MTS1/CDK41 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Caner Res 54 : 3396-3397
15. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368 : 753-756
16. kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372 : 570-573
17. Peter M, Herskowitz I (1994) Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79 : 181-184
18. Kip1. a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78 : 59-66
19. KiP1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8 : 9-22
20. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causins specific inhibition of cyclin D/ CDK4. Nature 366 : 704-707
21. Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R. et al (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood 84 : 3781-3784
22. Slingerland JM, Hengst L, Pan C-H, Alexander D, Stampfer MR, Reed SI (1994) A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol Cell Biol 14 : 3683-3694
23. Spruck CH III. Gonzales-Zulueta M, Shibata A, Simoneau AR, Lin M, Gonzales F, Tsai YC, Jones PJ (1994) p16 gene in uncultured tumours. Nature 370 : 183-184
24. Toyoshima H, Hunter T (1994) p27. a novel inhibitor of Gl cyclin-Cdk protein kinase activity, is related to p21. Cell 78 : 67-74
25. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366 : 701-704